TCG Crossover Management, LLC Diversified Active

CIK: 0001839948 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value ($000): $1,264,902 (100.0% shares, 0.0% debt)

Holdings (33)

CGON CG ONCOLOGY, INC. 12.4%
Value ($000) $156,732 Shares 3,570,206 Est. Cost $40.84 Unrealized 0.0%
DYN DYNE THERAPEUTICS, INC 5.9%
Value ($000) $75,238 Shares 2,650,150 Est. Cost $16.62 Unrealized +36.1%
ASTRIA THERAPEUTICS, INC. 5.9%
Value ($000) $74,301 Shares 5,278,928 Est. Cost $14.07 Unrealized
SLN SILENCE THERAPEUTICS PLC 5.6%
Value ($000) $71,180 Shares 3,295,350 Est. Cost $14.21 Unrealized
GPCR STRUCTURE THERAPEUTICS INC 5.4%
Value ($000) $68,508 Shares 1,598,421 Est. Cost $43.22 Unrealized
AEROVATE THERAPEUTICS INC 5.1%
Value ($000) $65,092 Shares 2,201,274 Est. Cost $15.75 Unrealized
INHIBRX,INC 4.8%
Value ($000) $61,194 Shares 1,750,387 Est. Cost $18.35 Unrealized
KROS KEROS THERAPEUTICS, INC. 4.6%
Value ($000) $58,213 Shares 879,344 Est. Cost $59.30 Unrealized 0.0%
GERN GERON CORP 4.5%
Value ($000) $57,392 Shares 17,391,639 Est. Cost $1.89 Unrealized +18.4%
SVRA SAVARA INC. 3.9%
Value ($000) $49,800 Shares 10,000,000 Est. Cost $3.56 Unrealized +35.5%
OCUL OCULAR THERAPEUTIX, INC. 3.8%
Value ($000) $48,404 Shares 5,319,148 Est. Cost $7.10 Unrealized 0.0%
COGT COGENT BIOSCIENCES INC 3.3%
Value ($000) $41,761 Shares 6,214,375 Est. Cost $9.23 Unrealized -33.0%
EWTX EDGEWISE THERAPEUTICS, INC. 3.3%
Value ($000) $41,455 Shares 2,272,728 Est. Cost $15.89 Unrealized 0.0%
MLYS MINERALYS THERAPEUTICS, INC. 3.3%
Value ($000) $41,121 Shares 3,185,185 Est. Cost $12.35 Unrealized 0.0%
MDGL MADRIGAL PHARMACEUTICALS INC 3.2%
Value ($000) $39,865 Shares 149,283 Est. Cost $110.42 Unrealized +113.4%
TOURMALINE BIO INC 2.7%
Value ($000) $33,837 Shares 1,477,593 Est. Cost $25.14 Unrealized
TYRA TYRA BIOSCIENCES INC 2.6%
Value ($000) $32,621 Shares 1,989,103 Est. Cost $12.71 Unrealized +29.1%
CMPS COMPASS PATHWAYS PLC 2.5%
Value ($000) $32,099 Shares 3,858,000 Est. Cost $7.40 Unrealized
KURA KURA ONCOLOGY INC 2.4%
Value ($000) $30,366 Shares 1,423,642 Est. Cost $14.54 Unrealized +33.7%
TARS TARSUS PHARMACEUTICALS, INC. 2.3%
Value ($000) $28,856 Shares 793,829 Est. Cost $17.70 Unrealized +66.2%
ADVERUM BIOTECHNOLOGIES, INC. 2.2%
Value ($000) $28,398 Shares 2,008,340 Est. Cost $14.14 Unrealized
SOLENO THERAPEUTIVS, INC. 1.9%
Value ($000) $23,540 Shares 550,000 Est. Cost $42.80 Unrealized
CNTA CENTESSA PHARMACEUTICALS PLC 1.8%
Value ($000) $23,061 Shares 2,040,816 Est. Cost $6.47 Unrealized
ABVX Abivax SA 1.2%
Value ($000) $15,730 Shares 1,100,000 Est. Cost $10.70 Unrealized
VISTAGEN THERAPEUTICS INC 1.1%
Value ($000) $14,132 Shares 2,676,580 Est. Cost $5.14 Unrealized
KALV KALVISTA PHARMACEUTICALS, INC 1.1%
Value ($000) $13,797 Shares 1,163,356 Est. Cost $5.36 Unrealized +148.9%
CCCC C4 THERAPEUTICS, INC. 0.8%
Value ($000) $10,430 Shares 1,276,574 Est. Cost $5.83 Unrealized +32.9%
TRDA ENTRADA THERAPEUTICS INC 0.7%
Value ($000) $8,289 Shares 584,955 Est. Cost $17.12 Unrealized
ANTX AN2 Therapeutics, Inc. 0.4%
Value ($000) $5,054 Shares 1,555,118 Est. Cost $9.33 Unrealized +16.6%
KOD KODIAK SCIENCES INC 0.4%
Value ($000) $4,734 Shares 899,999 Est. Cost $4.10 Unrealized +19.4%
VTYX VENTYX BIOSCIENCES, INC 0.4%
Value ($000) $4,486 Shares 815,724 Est. Cost $29.94 Unrealized -84.7%
NEKTAR THERAPEUTICS 0.3%
Value ($000) $3,737 Shares 4,000,000 Est. Cost $0.93 Unrealized
CABA CABALETTA BIO, INC 0.1%
Value ($000) $1,481 Shares 86,795 Est. Cost $3.64 Unrealized +489.5%